In one of the largest financings this year, privately-held Proteus Digital Health raises $172M. The company is developing a "smart pill" that a patient swallows. It records data on the internal milieu and transmits it externally via a patch on the abdomen. Reactions with stomach juices provide the power.
One of Proteus' collaborators is Novartis (NVS +0.6%).
Investors include Novartis, Medtronic (MDT +0.2%), Oracle and Kaiser Permanente.